Trial Profile
Phase II Clinical Trial of Patients With High-Grade Glioma Treated With Intra-Arterial Carboplatin-Based Chemotherapy, Randomized to Treatment With or Without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant Against Severe Thrombocytopenia
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Sodium thiosulfate (Primary) ; Carboplatin; Cyclophosphamide; Etoposide
- Indications Glioma; Thrombocytopenia
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 03 May 2022 Planned End Date changed from 30 Apr 2023 to 30 Apr 2024.
- 03 May 2022 Planned primary completion date changed from 30 Apr 2022 to 30 Apr 2023.
- 15 Sep 2021 Status changed from recruiting to active, no longer recruiting.